Some studies [2,37] have shown high morbidity and mortality rates in HD patients with increases in acute phase positive reactants (s-CRP, fibrinogen), proinflammatory cytokines (IL-1, IL-6, tumour necrosis factor alpha: TNF-α), and decreases in s-albumin, and transferrin level. The gene discussed is IL6; the disease is Huntington disease.